Talphera (TLPH) FCF Margin Growth (3y) (2014 - 2025)
Powered by 
Analysis
Talphera (TLPH) FCF Margin Growth (3y) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -2,024.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1,067.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -1,272.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -2,228.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -5,426.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4,612.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -203.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.75 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2023 | -32,702.00 |
| Sep 30, 2023 | -193,211.00 |
| Jun 30, 2023 | -177,319.00 |
| Mar 31, 2023 | 267,229.00 |
| Mar 31, 2022 | 320,313.00 |
| Dec 31, 2021 | -40.01 Mn |
| Sep 30, 2021 | 149,905.00 |
| Jun 30, 2021 | -143,784.00 |
| Mar 31, 2021 | 30,599.00 |
| Dec 31, 2020 | -18,832.00 |
| Sep 30, 2020 | -10,568.00 |
| Jun 30, 2020 | 4,870.00 |
| Mar 31, 2020 | -348,055.00 |
| Dec 31, 2019 | -284,207.00 |
| Sep 30, 2019 | -193,859.00 |
| Jun 30, 2019 | -124,502.00 |
| Mar 31, 2019 | -503,233.00 |
| Dec 31, 2018 | -189,172.00 |
| Sep 30, 2018 | -168,350.00 |